Literature DB >> 30733274

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia.

Ramzi Abboud1, Se Young Han2, Eric J Duncavage1, Amanda F Cashen1, Cara Lunn Shirai1, John S Welch1, John F DiPersio1, Camille N Abboud3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30733274      PMCID： PMC6442953          DOI： 10.3324/haematol.2018.209478

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Successful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine.

Authors:  Anyou Wang; Xiaoyan Cai; Ping Qiang; Qiaohong Duan
Journal:  Leuk Lymphoma       Date:  2017-08-01

2.  [Decitabine inhibits cell proliferation and induces apoptosis of all-trans retinoid acid-resistant acute promyelocytic leukemia NB4-R2 cell line].

Authors:  Mu-Jun Xiong; Ruo-Zhi Xiao; Yan Chen; Jia-Jie Chen; Zi-Jie Long; Xing Wu; Dong-Jun Lin
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2012-02

3.  Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008.

Authors:  Yiming Chen; Hagop Kantarjian; Haijun Wang; Jorge Cortes; Farhad Ravandi
Journal:  Cancer       Date:  2012-06-15       Impact factor: 6.860

4.  Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

Authors:  Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles A Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

5.  PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.

Authors:  Joost H A Martens; Arie B Brinkman; Femke Simmer; Kees-Jan Francoijs; Angela Nebbioso; Felicetto Ferrara; Lucia Altucci; Hendrik G Stunnenberg
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

6.  Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.

Authors:  Luciano Di Croce; Veronica A Raker; Massimo Corsaro; Francesco Fazi; Mirco Fanelli; Mario Faretta; Francois Fuks; Francesco Lo Coco; Tony Kouzarides; Clara Nervi; Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

7.  Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.

Authors:  Megan H McDonnell; Elton T Smith; Edward H Lipford; Jonathan M Gerber; Michael R Grunwald
Journal:  Hematol Oncol Stem Cell Ther       Date:  2016-01-16

8.  Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Authors:  Francesco Lo-Coco; Giuseppe Avvisati; Marco Vignetti; Christian Thiede; Sonia Maria Orlando; Simona Iacobelli; Felicetto Ferrara; Paola Fazi; Laura Cicconi; Eros Di Bona; Giorgina Specchia; Simona Sica; Mariadomenica Divona; Alessandro Levis; Walter Fiedler; Elisa Cerqui; Massimo Breccia; Giuseppe Fioritoni; Helmut R Salih; Mario Cazzola; Lorella Melillo; Angelo M Carella; Christian H Brandts; Enrica Morra; Marie von Lilienfeld-Toal; Bernd Hertenstein; Mohammed Wattad; Michael Lübbert; Matthias Hänel; Norbert Schmitz; Hartmut Link; Maria Grazia Kropp; Alessandro Rambaldi; Giorgio La Nasa; Mario Luppi; Fabio Ciceri; Olimpia Finizio; Adriano Venditti; Francesco Fabbiano; Konstanze Döhner; Michaela Sauer; Arnold Ganser; Sergio Amadori; Franco Mandelli; Hartmut Döhner; Gerhard Ehninger; Richard F Schlenk; Uwe Platzbecker
Journal:  N Engl J Med       Date:  2013-07-11       Impact factor: 91.245

9.  The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.

Authors:  Emiliano Fabiani; Giulia Falconi; Nélida Inés Noguera; Ernestina Saulle; Laura Cicconi; Mariadomenica Divona; Cristina Banella; Alessandra Picardi; Anna Maria Cerio; Letizia Boe; Massimo Sanchez; Elvira Pelosi; Ugo Testa; Francesco Lo-Coco; Maria Teresa Voso
Journal:  Oncotarget       Date:  2017-09-20

10.  Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Authors:  V Madan; P Shyamsunder; L Han; A Mayakonda; Y Nagata; J Sundaresan; D Kanojia; K Yoshida; S Ganesan; N Hattori; N Fulton; K-T Tan; T Alpermann; M-C Kuo; S Rostami; J Matthews; M Sanada; L-Z Liu; Y Shiraishi; S Miyano; E Chendamarai; H-A Hou; G Malnassy; T Ma; M Garg; L-W Ding; Q-Y Sun; W Chien; T Ikezoe; M Lill; A Biondi; R A Larson; B L Powell; M Lübbert; W J Chng; H-F Tien; M Heuser; A Ganser; M Koren-Michowitz; S M Kornblau; H M Kantarjian; D Nowak; W-K Hofmann; H Yang; W Stock; A Ghavamzadeh; K Alimoghaddam; T Haferlach; S Ogawa; L-Y Shih; V Mathews; H P Koeffler
Journal:  Leukemia       Date:  2016-04-11       Impact factor: 11.528
View more
  1 in total

1.  Clinical Response to Venetoclax and Decitabine in Acute Promyelocytic Leukemia With a Novel RARA-THRAP3 Fusion: A Case Report.

Authors:  Baoquan Song; Xin Wang; Xin Kong; Man Wang; Li Yao; Hongjie Shen; Jian Zhang; Huiying Qiu
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.